Nature·6 min read·hard
A tumor-on-a-chip model reveals and targets reciprocal macrophage-NK cell crosstalk to advance immunotherapy screening
H
Han, Xiahe
✦AI Summary
Researchers have developed a 'tumor-on-a-chip' platform to study the immunosuppressive interactions between macrophages and NK cells in liver tumors. This model successfully identified drug combinations that overcome resistance to immunotherapy, offering a tool for personalized cancer treatment.
Why it matters
This technology advances precision medicine by allowing researchers to test complex drug interactions in a controlled, patient-specific environment.
Microsystems & Nanoengineering volume 12 , Article number: 295 ( 2026 ) Cite this article
sciencehealthtechnology
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in